Kroemer G, Hirsch F, González-García A, Martínez C
CNRS-UPR420, Villejuif, France.
Autoimmunity. 1996;24(1):25-33. doi: 10.3109/08916939608995354.
By virtue of their functional antagonism, Th1 cells or cells producing the same cytokines as Th1 cells may behave as "suppressor cells' with respect to Th2 cells and vice versa. An excessive Th1- or Th2-like response may favor the development of different autoimmune diseases. As can be expected from their physiological role, Th-1 cytokines participate in autoimmune diseases with a preferential delayed type hypersensitivity component, i.e. in those diseases in which cytotoxic T cells attack organ-specific target cells. Autoimmune diseases with a predominant Th1 component include experimental autoimmune encephalitis and insulin-dependent diabetes mellitus. In contrast, Th2-type responses participate in systemic autoimmune diseases with a strong humoral component. Such diseases probably include certain drug-induced states of autoaggression, namely mercury-induced autoimmune disease and chlorpromazine-induced autoimmunity. It is tempting to speculate that therapeutic interventions designed to recover a normal Th1/Th2 balance will provide a useful etiological strategy for the re-establishment of self-tolerance.
由于Th1细胞或产生与Th1细胞相同细胞因子的细胞具有功能拮抗作用,它们相对于Th2细胞可能表现为“抑制细胞”,反之亦然。过度的Th1样或Th2样反应可能有利于不同自身免疫性疾病的发展。正如从它们的生理作用所预期的那样,Th1细胞因子参与具有优先迟发型超敏反应成分的自身免疫性疾病,即在那些细胞毒性T细胞攻击器官特异性靶细胞的疾病中。具有主要Th1成分的自身免疫性疾病包括实验性自身免疫性脑脊髓炎和胰岛素依赖型糖尿病。相反,Th2型反应参与具有强烈体液成分的全身性自身免疫性疾病。这类疾病可能包括某些药物诱导的自身攻击状态,即汞诱导的自身免疫性疾病和氯丙嗪诱导的自身免疫。很诱人的推测是,旨在恢复正常Th1/Th2平衡的治疗干预将为重新建立自身耐受性提供一种有用的病因学策略。